AdaptHealth (AHCO) Operating Income Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn | -76.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.31% |
| Dec 31, 2025 | -175.03% |
| Sep 30, 2025 | -2.77% |
| Jun 30, 2025 | 52.27% |
| Mar 31, 2025 | -54.15% |
| Dec 31, 2024 | 144.84% |
| Sep 30, 2024 | 113.77% |
| Jun 30, 2024 | -4.08% |
| Mar 31, 2024 | 93.04% |
| Dec 31, 2023 | -914.77% |
| Sep 30, 2023 | -970.72% |
| Jun 30, 2023 | -8.31% |
| Mar 31, 2023 | -49.22% |
| Dec 31, 2022 | -61.30% |
| Sep 30, 2022 | -30.06% |
| Jun 30, 2022 | -9.52% |
| Mar 31, 2022 | 234.56% |
| Dec 31, 2021 | 101.41% |
| Sep 30, 2021 | 471.01% |
| Jun 30, 2021 | 320.08% |
| Mar 31, 2021 | 87.46% |
| Dec 31, 2020 | 8,560.86% |
| Sep 30, 2020 | 51.98% |
| Jun 30, 2020 | 4.42% |
| Mar 31, 2020 | 53.70% |
| Dec 31, 2019 | -98.76% |
| Sep 30, 2019 | 2,061.55% |
| Jun 30, 2019 | 6,461.21% |
| Mar 31, 2019 | 7,473.87% |